Stocks to Watch: The Horse Race

I have made a trade and now we wait to see how it turns out.

I have picked us up 246 shares of AKRX at $1.22 when I last posted. The total cost was $308.08 after commission. I see this trade making us $100+. Here are the reasons why.

First, Akorn, Inc., as I mentioned had a lot of positives going for it. It was undervalued and the price we bough it at was great.
Second, it was side trading and it broke out, like I predicted and that breakout has been really good.
Third, the FDA approved one of its drugs.

The approval is great news. Already in the aftermarket, AKRX is at $1.50. I see this stock breaking $2 tomorrow. I haven't decided a sell point yet but I will look at the price action in the morning.

If, Akorn, Inc. does the proper PR tomorrow and really pushes it, this stock could see $2.50+. It will come down to Akorn, Inc. to push this great news for the stock to really jump. With such news I may take early profits and buy into some of the other stocks I have been watching, or let this trade ride to some substantial profits. I will update soon with the trading plan.

Tomorrow's first couple hours will be important on deciding how to handle AKRX, espeially how Akorn, Inc. publicizes its success.

WIWS
Disclaimer: These are not recommendations to buy or sell. Invest at your own risk. Where Is Wall St. is not responsible for your own decisions.